Literature DB >> 9372478

Effects of physical activity and diet on lipoprotein(a).

L T Mackinnon1, L Hubinger, F Lepre.   

Abstract

Lipoprotein(a) [Lp(a)] represents a class of lipoproteins with some structural similarity to low density lipoprotein (LDL), but containing a unique apoprotein, apoprotein(a). First reported in 1963, Lp(a) is now considered to have an independent role in the development of atherosclerotic lesions. The level of Lp(a) in the blood is under strong genetic influence and does not appear to be alterable by lifestyle factors known to influence other lipoproteins. Regular moderate exercise has been shown to favorably alter other lipoproteins, and recent attention has focused on whether Lp(a) level can be influenced by physical activity. Current data from cross-sectional and intervention studies show little effect of moderate exercise on serum Lp(a) concentration. One possible exception may be an elevation of serum Lp(a) concentration in adult endurance and power athletes who exercise intensely on a daily basis. However, not all studies have taken into account possible racial or ethnic differences in Lp(a) concentrations and the skewed distribution observed within most populations. Standard dietary intervention such as a low fat diet recommended for weight loss and control of other blood lipids has little effect on serum Lp(a) level. At present, serum Lp(a) concentration does not appear to be significantly altered by realistic dietary changes and moderate physical activity as recommended for health. The synergistic effect on cardiovascular disease risk when both LDL-cholesterol and Lp(a) are elevated highlight the importance of attending to those risk factors that can be modified by exercise and other lifestyle changes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372478     DOI: 10.1097/00005768-199711000-00007

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  8 in total

Review 1.  Lipoprotein(a): A Lipoprotein Whose Time Has Come.

Authors:  Erik Kelly; Linda Hemphill
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

Review 2.  The role of non-LDL:non-HDL particles in atherosclerosis.

Authors:  Jere P Segrest
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 3.  Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.

Authors:  Nishant P Shah; Neha J Pajidipati; Robert W McGarrah; Ann Marie Navar; Sreekanth Vemulapalli; Michael A Blazing; Svati H Shah; Adrian F Hernandez; Manesh R Patel
Journal:  Am J Cardiol       Date:  2020-04-07       Impact factor: 2.778

4.  Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease.

Authors:  Richard J Wood; Jeff S Volek; Steven R Davis; Carly Dell'Ova; Maria Luz Fernandez
Journal:  Nutr Metab (Lond)       Date:  2006-05-04       Impact factor: 4.169

5.  Changes in oxidized LDL during a half marathon in athletes with spinal cord injuries.

Authors:  Toshihito Mitsui; Tomoyuki Ito; Yusuke Sasaki; Takashi Kawasaki; Takeshi Nakamura; Yukihide Nishimura; Tatsuru Ibusuki; Yukiharu Higuchi; Sayoko Hosoe; Fumiaki Ito; Fumihiro Tajima
Journal:  Spinal Cord Ser Cases       Date:  2017-05-11

6.  Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.

Authors:  Ryo Naito; Hiroyuki Daida; Daisaku Masuda; Mariko Harada-Shiba; Hidenori Arai; Hideaki Bujo; Shun Ishibashi; Nobuhiko Koga; Shinichi Oikawa; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2021-08-30       Impact factor: 4.394

Review 7.  Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.

Authors:  Motasim M Jawi; Jiri Frohlich; Sammy Y Chan
Journal:  J Lipids       Date:  2020-02-01

8.  Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone.

Authors:  David M Diamond; Abdullah A Alabdulgader; Michel de Lorgeril; Zoe Harcombe; Malcolm Kendrick; Aseem Malhotra; Blair O'Neill; Uffe Ravnskov; Sherif Sultan; Jeff S Volek
Journal:  BMJ Evid Based Med       Date:  2020-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.